Therapy aimed at reducing androgen over-production in PCOS fails to ameliorate co-morbid IR: no significant improvement in insulin dynamics is observed following long-term treatment of adolescents with PCOS with GnRH analogues [111-114]. This evidence concerns the gene INS and polycystic ovary syndrome.